A carregar...

Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence

BACKGROUND: The ERBB2 oncogene hypothesis is challenged in hepatocellular carcinoma (HCC) with the conflicting evidences of human epidermal growth factor receptor 2 (HER2) overexpression. HER2 could be a new target as a treatment option for HCC as well as tumor recurrence after surgery. HER2 in HCC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Shi, Ji‐Hua, Guo, Wen‐Zhi, Jin, Yang, Zhang, Hua-Peng, Pang, Chun, Li, Jie, Line, Pål‐Dag, Zhang, Shui‐Jun
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6434216/
https://ncbi.nlm.nih.gov/pubmed/30714677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!